Alpha Teknova (TKNO) Gains from Investment Securities (2020 - 2025)
Alpha Teknova (TKNO) reported Gains from Investment Securities of $5.3 million for Q4 2025, up 32.05% year-over-year from $4.0 million in Q4 2024, and up 7679.2% quarter-over-quarter from $67769.0 in Q3 2025.
Alpha Teknova (TKNO) Gains from Investment Securities (2020 - 2025) Analysis & Trends
Alpha Teknova (TKNO) has 6 years of Gains from Investment Securities data on file, last reported at $5.3 million in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $5.3 million, up 32.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.3 million (up 32.05% YoY), and the FY2025 annual result was $5.3 million, up 32.05% from the prior year.
- Gains from Investment Securities improved to $5.3 million in Q4 2025 per TKNO's latest filing, from $67769.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.4 billion in Q2 2025 and troughed at -$37000.0 in Q4 2021.
- A 5-year average of $141.0 million and a median of $837475.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities surged 37412.65% in 2022, then tumbled 97.78% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$37000.0 in 2021, then jumped by 1964.86% to $690000.0 in 2022, then plunged by 86.23% to $95000.0 in 2023, then soared by 4102.46% to $4.0 million in 2024, then surged by 32.05% to $5.3 million in 2025.
- Business Quant data shows TKNO's Gains from Investment Securities at $5.3 million in Q4 2025, $67769.0 in Q3 2025, and $1.4 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Alpha Teknova | 239.62 Mn | 221.84 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.27 Mn |
| Dec 31, 2025 | 5.27 Mn |
| Sep 30, 2025 | 67,769.00 |
| Sep 30, 2025 | 67,769.00 |
| Jun 30, 2025 | 1.39 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.22 Bn |
| Dec 31, 2024 | 3.99 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Sep 30, 2024 | 60,000.00 |
| Sep 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 4.03 Mn |
| Jun 30, 2024 | 4.03 Mn |
| Mar 31, 2024 | 4.37 Mn |
| Mar 31, 2024 | 4.37 Mn |
| Dec 31, 2023 | 95,000.00 |
| Dec 31, 2023 | 95,000.00 |
| Sep 30, 2023 | 263,348.00 |
| Sep 30, 2023 | 263,348.00 |